Flatiron roche.
Feb 14, 2018 · Roche and Flatiron Health, Inc.
Flatiron roche Mar 2, 2018 · Roche has signed an agreement to acquire all shares of Flatiron Health, a health care technology and services company headquartered in New York City, for $1. 6 billion. We are proud to have made a positive impact on patients’ lives in 2024 with the launch of two new medicines – Itovebi for a Apr 9, 2018 · Flatiron makes software to improve the workflow in cancer clinics and aggregates anonymized data from that software to share with pharmaceutical companies and research institutes. Flatiron Health is a market leader in oncology-specific electronic health record (EHR) software as well as in the curation and development of real-world evidence for cancer We partner with hundreds of cancer centers, 20+ top global developers of oncology therapeutics, and researchers and regulators around the world. Jul 23, 2025 · Roche’s Flatiron Health is celebrating a milestone. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the collaboration with Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point of care solutions in oncology, to integrate its comprehensive genomic testing directly into Flatiron’s cloud-based Electronic Roche is considering divesting cancer data specialist Flatiron Health, Thoma Bravo is exploring a sale of compliance software maker Cority, and fintech startup Klarna is preparing a secondary Feb 18, 2018 · Roche's recently announced acquisition of the oncology data company Flatiron Health for $2. Asset acquisitions. Food & Drug Administration, the National Comprehensive Cancer Network® and others, and we are a founding member of the RWE Alliance. Mar 6, 2020 · Eight years later, at 32, they sold their next company, Flatiron Health, to Roche for nearly $2 billion. Daniel O’Day, CEO Roche Pharmaceuticals said, “This is an important step in our personalised healthcare strategy for Roche, as we believe that regulatory-grade real-world evidence is a key ingredient to accelerate the development of, and access to, new cancer treatments. Construction of FlatIron Crossing Village included 230,000 square feet of an outdoor town-like retail and entertainment area Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern, connected oncology ecosystem. , a global company, with offices in the United States, Germany, and Japan. Apr 9, 2018 · Roche (OTC: RHHBY) said today it closed its $1. The acquisition aimed to leverage real-world evidence to enhance Roche Roche expects to further increase its dividend in Swiss francs. Flatiron – Roche Group acquisition to advance use of real-world evidence in regulatory decision-making and at point of care Foundation Medicine (FMI) – Roche Group acquisition to further develop FMI's comprehensive genomic profiling platform and support the Roche Group’s PHC strategy Aug 7, 2024 · The report on Roche mulling divesting Flatiron comes after the drugmaker last month raised its full-year earnings forecast driven by strong demand for newer drugs such as its eye medicine Vabysmo. Through clinical and data science, they translate patient experiences into real-world evidence to improve treatment 3 days ago · When it bought Flatiron in 2018, Roche's former pharma chief executive Daniel O'Day said: "This is an important step in our personalised healthcare strategy for Roche, as we believe that Flatiron Health to continue its operations as a separate legal entity Roche (SIX: RO, ROG; OTCQX: RHHBY) and Flatiron Health, Inc. ’s venture arm, Flatiron Health creates and sells oncology-focused electronic health record software, as well as developing real-world data platforms for cancer research. com @FlatironHealth About MassiveBio Massive Bio is a global leader in using artificial intelligence to streamline patient identification and recruitment for clinical trials. 9 billion acquisition of Flatiron Health, the Alphabet-backed, cancer-focused digital health Flatiron Health was founded in 2012 and has been an independent affiliate of the Roche Group since 2018. Flatiron announced its renewed collaboration with the US FDA on specific research projects to advance the use of real-world data and explore the potential of using real-world evidence for regulatory purposes. Apr 6, 2018 · Roche noted that Flatiron partners with more than 265 community cancer clinics, six major academic research centers, and 14 therapeutic oncology companies. Flatiron Health, the leader in cloud-based oncology software, today announced a Series C fundraising round totaling $175 million, led by Roche. announced today that the two partners have signed a definitive agreement under which Roche will acquire all shares of Flatiron Health, following on from an existing equity stake of 12. Reimagining the infrastructure of cancer care | Flatiron Health’s mission is to improve and extend lives by learning from the experience of every Feb 16, 2018 · Roche (RHHBY) announces that it will acquire Flatiron Health to accelerate development and delivery of breakthrough drugs for cancer patients. Roche, one of the world’s largest pharmaceutical companies, is so bullish on the prospects for this platform that they acquired Flatiron earlier this year for $1. 9 billion [9]. 9 billion in 2018, according to a report by the Financial Times. Feb 15, 2018 · Roche currently owns 12. " The drugmaker noted that following completion of the acquisition, Flatiron will continue to operate as a separate entity. Together, we can be smarter. During the Second World War, Roche collaborated with the Nazi regime in Germany and used forced labour in its German and Polish Flatiron Horizon is the driving force behind our real-world evidence solutions, seamlessly integrating the richest labeled oncology data in the world, Flatiron’s proprietary curation methods and disease-specific ML models, technology, oncology experience, and expertise. Feb 16, 2018 · Switzerland-headquartered biopharma player Roche is to acquire New York start-up Flatiron Health in a $1. It operates as a Cloud-based practice management tool for providers. Roche reports strong 2024 results with 7% sales growth; fourth quarter marks third straight quarter of 9% growth Group sales grew by 7%1 at constant exchange rates (CER; 3% in CHF), driven by strong demand for both medicines and diagnostics. Jun 2, 2025 · Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we transform patients’ real-life experiences into knowledge and create a more modern, connected oncology ecosystem. com. Roche CEO Thomas Schinecker: “2024 was a strong year for Roche. Flatiron Health creates software for cancer centers that organizes patient data and Sep 25, 2023 · Roche Holding AG owns 4 companies, including Hoffmann-LA Roche Inc, Flatiron Health and Kapa Biosystems. Apr 5, 2018 · Roche today announced that it has completed the acquisition of Flatiron Health, a privately held healthcare technology and services company headquartered in New York City, US. Its top competitor Aug 7, 2024 · Roche had paid $1. NRG Oncology is a Aug 7, 2024 · Roche had paid $1. Nov 12, 2018 · In only the last 3 months, Flatiron data has enabled 29 research abstracts, manuscripts, and published studies [8]. May 22, 2025 · Flatiron’s 2025 ASCO research showcases the power of longitudinal, real-world oncology data and innovative AI-driven methodologies to generate actionable evidence, address health equity, and Roche completes acquisition of Flatiron Health Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has completed the acquisition of Flatiron Health, a privately held healthcare technology and services company headquartered in New York City, US. BASEL, SWITZERLAND Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has completed the acquisition of Flatiron Health, a privately held healthcare technology and services company headquartered in New York City, US. Feb 16, 2018 · Backed by both Roche and Alphabet Inc. 9 billion to speed development of cancer medicines and support its Jul 23, 2025 · Flatiron Health, which has built an oncology-focused EHR network and a de-identified database with more than 4 million patient records, is an independent affiliate of the Roche Group, as previously reported by Healthcare Innovation. The deal, which would raise Roche’s stake from 12. Clinicians, researchers, and regulators rely on Flatiron technology and evidence to learn faster and power smarter care for every patient. com @FlatironHealth Utility of automated data transfer for cancer clinical trials and considerations for implementation. Flatiron's data aids Roche's oncology R&D (FlatIron) Accelerate Action - International Women's Day (IWD) 2025 - 06 Mar 2025 Ignite Collaboration in a Complex World - with Sascha Kluewer Roche is committed to improving global healthcare. , the company’s vice president of Flatiron Health is an independent affiliate of the Roche Group. In 2016, Roche led a $175 million investment into Flatiron, in part to help the Swiss company harness the deluge of still-underutilised data Feb 16, 2018 · Roche says expanding its presence in personalized medicine and oncology explains its planned $1. , Germany and Japan, Flatiron Aug 13, 2024 · Zoom in: Roche hired Citigroup to advise on options, which include a full divest or a partial sale to "a partner that could help run the business," per the FT. Flatiron Health is a healthtech company dedicated to helping cancer centers thrive and deliver better care for patients today and tomorrow. Feb 16, 2018 · Swiss pharma Roche AG on Thursday snapped up oncology EHR company Flatiron Health, paying $1. Jan 29, 2025 · Roche CEO Thomas Schinecker: “2024 was a strong year for Roche. Feb 16, 2018 · Flatiron Health, a healthcare technology and services company whose offerings are designed to support cancer-care providers and life science companies, would be acquired by Roche for $1. Flatiron Health is an independent affiliate of the Roche Group. Feb 15, 2018 · Roche, the global pharmaceutical company from Switzerland, today announced it will scoop up Flatiron Health, a startup analyzing real-time oncology data to help cancer patients and doctors, in a Who are Flatiron’s competitors? Jana Analysis, Fabric Genomics, NantHealth, HealthEC, and SOPHiA GENETICS are some of the 22 competitors of Flatiron. 6 percent of Flatiron. 9-billion acquisition of Flatiron Health will make the Swiss pharma the owner of Flatiron's technology platform and a cache of over 2 million cancer patients Apr 16, 2025 · Flatiron Health is an independent affiliate of the Roche Group. Feb 15, 2018 · Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. 9 billion acquisition of Flatiron Health, the Alphabet-backed, cancer-focused digital health Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Oct 29, 2025 · Cancer health tech company Flatiron Health has unveiled six new blood cancer data sets that together comprise information from more than half a million patient records, the Roche subsidiary Flatiron Health | 91,311 followers on LinkedIn. Their support is centered around Flatiron continuing to operate autonomously alongside their other business units and divisions such as Roche Pharmaceuticals and Roche Diagnostics. About Flatiron Health Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. 9bn deal. " FirstWord Project Description Roche was responsible for the construction of an enclosed shopping mall, which included building pad preparation for four major anchor tenants and the construction of 777,000 square feet of specialty retail shops including an expansive food court. Participant With deep expertise in oncology evidence generation and HTA decision making, learn why Flatiron is biopharma's trusted global RWE partner for planning and executing value and market access studies. The takeover gives Roche ownership of the cancer software and real-world evidence that turned Google Ventures-backed Flatiron into Feb 14, 2018 · Roche and Flatiron Health, Inc. 9 billion to acquire the remaining 87. Because transforming cancer care takes all of us. Oct 31, 2025 · Flatiron Health is an acquired company based in New York City (United States), founded in 2012 by Nat Turner and Zach Weinberg. Feb 16, 2018 · One of the world’s largest pharmaceutical companies has agreed to buy Flatiron Health, a health IT company founded by two former Google employees. Plans at Flatiron Health and Spark Therapeutics incurred total costs of CHF 677 million, which include CHF 502 million for impairments of property, plant and equipment and right-of-use assets and commercial software intangible assets resulting from the impairment of goodwill at these two businesses. , a company incorporated in the State of Delaware, and its subsidiaries (‘RHI’ or ‘the RHI Group’). Cancer is smart. Jul 23, 2025 · Founded in 2012 and acquired by Roche in 2018, Flatiron uses deidentified patient data to create tools for investigators and oncology practices to aid clinical decision-making, measure quality Feb 16, 2018 · Roche has announced the acquisition of Flatiron Health in a deal worth $1. Flatiron, founded in 2012 with backing from Alphabet (Google's parent company), caught Roche's attention after it worked with pharma companies and regulators to develop new approaches for using real-world evidence in Feb 16, 2018 · The big headline out of the health care M&A world today is Swiss pharmaceutical giant Roche’s $1. (‘Flatiron Health’) for USD 1. 6%. [11] In 1934, it became the first company to mass-produce synthetic vitamin C, under the brand name Redoxon. 9 billion in 2018 in an effort to advance Roche’s personalised healthcare strategy in oncology using Flatiron’s real-world evidence databank. 9 billion to speed development of cancer medicines and support its Our point of care solutions help practices remain financially viable, run more efficient clinical trials, and stay one step ahead of healthcare changes. Through clinical and data science, we translate patient experiences into real-world evidence to improve treatment, inform policy, and advance research. A career at Flatiron is a chance to work alongside some of the brightest and most compassionate minds in oncology, technology, and research. 46 Flatiron Roche jobs available on Indeed. Although Flatiron is a separate legal entity from Roche, the drugmaker's ownership has deterred its peers from doing business with Flatiron, hurting sales. Feb 16, 2018 · Roche has struck a $1. Aug 7, 2024 · Roche acquired Flatiron Health for $1. Founded in 2012, Flatiron became an independent affiliate of the Roche Group in 2018. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern, connected oncology ecosystem. When was Flatiron acquired? Flatiron was acquired on 05-Apr-2018. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern Explore the latest Flatiron-authored research on real-world data, clinical research technology, and innovations at the point of care. Aug 7, 2024 · Swiss pharmaceutical company Roche is considering divesting cancer data specialist Flatiron Health, the Financial Times reported on Wednesday, citing people familiar with the matter. Flatiron Health is an independent affiliate of the Roche We’re building a diverse, global workforce of kind and passionate people to propel our mission forward. 9 billion acquisition of Flatiron Health, the Alphabet-backed, cancer-focused digital health Feb 15, 2018 · In 2016, Roche led a $175 million investment into Flatiron, in part to help the Swiss company harness the deluge of still-underutilized data collected from cancer patients with the New York City Aug 13, 2024 · In February 2018, Roche Pharmaceuticals acquired Flatiron Health, a company specializing in oncology data, for $1. Feb 15, 2018 · Swiss pharma giant Roche is buying Flatiron, which was founded by two ex-Google employees and aims to improve cancer treatment. Core earnings per share exceeded the guidance raised at half year. Jan 25, 2022 · Flatiron Health, a real-world data company focused on cancer research, inked a partnership with Japan’s National Cancer Center Hospital East (NCCHE), marking a major step in the company's internati Feb 15, 2018 · Roche described Flatiron, which was founded by ex-Google employees Nat Turner and Zach Weinberg as "a market leader in oncology-specific electronic health record software, as well as the curation and development of real-world evidence for cancer research. Over the last year, the company has tripled the size of its international oncology network across the U. Prior to this, Roche had a 12. The round was led by Google Ventures with participation from First Round Capital, Laboratory Corporation of America, Great Oaks Capital These financial statements are the Annual Financial Statements of Roche Holdings, Inc. New York City-based Flatiron Health designs and develops oncology-specific Feb 12, 2025 · Flatiron Health is having success in boosting cancer care data processing with AI, sometimes achieving dramatically faster study speeds. Sep 25, 2025 · Flatiron Health is a healthtech company dedicated to helping cancer centers thrive and deliver better care for patients today and tomorrow. 9 billion. 4% of the privately held tech company not already owned by Roche Jan 9, 2024 · Announced Monday, it’ll see Caris combine its database with Roche-owned Flatiron Health’s own AI-powered platform of real-world oncology data—with an aim, much like that of the ConcertAI On April 5, 2018 the Pharmaceuticals Division acquired a 100% controlling interest in Flatiron Health, Inc. Feb 16, 2018 · Roche has signed a deal to buy Flatiron Health, a startup tech firm focused on improving cancer treatment, which was founded with backing from Google’s parent firm Alphabet. . Flatiron Health UK Ltd operates separately from other Flatiron companies, with local operations, employees, and processes. Flatiron’s goal is to accelerate cancer research and improve patient care by enabling cancer researchers and care May 17, 2020 · Nat Turner, Flatiron Health Co-Founder and CEO said, “Roche has been a tremendous partner to us over the past two years and shares our vision for building a learning healthcare platform in oncology ultimately designed to improve the lives of cancer patients. Who acquired Flatiron? Flatiron was acquired by Roche. New financing to build out industry’s first data platform for oncology NEW YORK, NY Flatiron Health, developers of the industry’s first oncology data platform, today announced that it has raised $8 million in a Series A round of venture capital financing. 9 billion deal to acquire Flatiron Health. 6 percent to outright ownership, is subject to regulatory approval and is expected to close in the first half of […] Oct 9, 2024 · Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data (RWD), today announced a New financing to build out industry’s first data platform for oncology NEW YORK, NY Flatiron Health, developers of the industry’s first oncology data platform, today announced that it has raised $8 million in a Series A round of venture capital financing. Flatiron Health is a market leader in oncology-specific electronic health record (EHR) software as well as in the curation and development of real-world evidence for cancer research. Switzerland-based Roche Group has agreed to pay NEW YORK, NY Flatiron Health, Foundation Medicine, and Genentech, a member of the Roche Group, in partnership with community and academic oncology practices, have launched the Prospective Clinico-Genomic (PCG) Study, NCT04180176. cancer data company Flatiron Health for $1. Here, Law360 breaks down these and other notable deal rumors from the past week. [2] This software is its market leading, oncology-specific electronic health record platform. In years since, we’ve expanded our commitment to advance research and treatment for patients around the globe. Mar 19, 2025 · Flatiron Health is an independent affiliate of the Roche Group. Global pharmaceutical company Roche has agreed to buy Flatiron Health, a start-up focused on using Flatiron Health is an independent affiliate of the Roche Group. Feb 16, 2018 · Flatiron Health expects to maintain its current business model in the transaction. S. K. On Friday, the global pharmaceuticals conglomerate said the deal will "accelerate industry-wide development and Mar 19, 2025 · Health tech company Flatiron Health, an independent affiliate of the Roche Group, is expanding the reach of its clinical data capture tool through a pact with NRG Oncology. D. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern Feb 15, 2018 · Swiss drugmaker Roche Holding AG said on Thursday it would buy the rest of U. 6% Aug 11, 2024 · Roche is reportedly considering the sale of Flatiron Health, a cancer data specialist that it acquired for $1. com @FlatironHealth About NRG Oncology NRG Oncology conducts practice-changing, multi-institutional clinical and translational research to improve the lives of patients with cancer. Keep reading to learn more about Roche Holding AG subsidiaries. com @FlatironHealth. Roche logo (1967–2021) Founded in 1896 by Fritz Hoffmann-La Roche, the company was known early on for producing various vitamin preparations and derivatives. Flatiron Health, a data-science software company, had emerged as an unlikely power player in 2016. Feb 16, 2018 · The big headline out of the health care M&A world today is Swiss pharmaceutical giant Roche’s $1. Flatiron Health is a healthtech company dedicated to helping cancer centres thrive and deliver better care for patients today and tomorrow. Apply to Customer Service Representative, Account Executive, Support Specialist and more! Roche is considering divesting cancer data specialist Flatiron Health, Thoma Bravo is exploring a sale of compliance software maker Cority, and fintech startup Klarna is preparing a secondary-share sale ahead of a planned IPO. Explore our open positions and apply today! Jun 21, 2023 · The health IT company Flatiron expanded its global footprint as part of a collaboration deal with Leeds Teaching Hospitals NHS Trust, one of the largest acute hospital trusts in Europe. In the fourth quarter, we continued our very positive momentum for the third consecutive quarter with Group sales growth of 9% (CER). Flatiron Health was founded in 2012; it became an independent affiliate of the Roche Group in 2018 following its acquisition by Roche. 9 billion for New-York based Flatiron Health in 2018 to speed its development of cancer medicines and support its efforts to price them based on how well they work. Aug 6, 2024 · Roche had paid $1. 9bn. Mar 12, 2018 · Nat Turner agreed to sell his company, Flatiron Health, to healthcare giant Roche in February for $1. May 7, 2025 · The duo had built the first team at Flatiron focused on machine learning, and, a few years after pharmaceutical giant Roche snapped up the company for $1. Flatiron Health UK is part of Flatiron Health Inc. We partner with the National Cancer Institute, the U. With its large network of community Feb 26, 2018 · Earlier this month, Roche, a global pharmaceutical giant, acquired Flatiron Health, an oncology-focused electronic health records (EHR) company, for $1. 1 billion represents a robust validation of the much-discussed but infrequently realized hypothesis that Mar 12, 2018 · Nat Turner, CEO of $2 billion startup Flatiron Health, says a cousin's battle with leukemia led him to his biggest success yet. Mar 9, 2018 · The recent acquisition of Flatiron by Roche raises two important questions: First, given that (as Andrew Matzkin of Health Advances observed) the Flatiron transaction is “putting smiles on a lot Flatiron Health Flatiron Health is a healthcare technology company that aims to improve lives by learning from the experience of every cancer patient. It enables swift and efficient curation of data and insights, empowering us to understand the narrative within the data Aug 7, 2024 · Roche is considering divesting Flatiron Health, highlighting the hazards big pharma can face when buying startups. Nov 25, 2024 · Flatiron Health, which has built up an oncology-focused EHR network and a de-identified database with more than 4 million patient records, recently announced a milestone of over 1,000 research publications using its EHR-derived real-world data. Neal Meropol, M. Aug 8, 2024 · Roche is considering divesting Flatiron Health six years after it bought the startup for $1. As a leading technology company in oncology, Flatiron Health is best positioned to provide the technology and data Join Flatiron FORUM to advance oncology research through real-world evidence, shaping health technology assessments and accelerating patient access to innovative therapies globally. 9 billion, they launched their own company. Jan 8, 2024 · Caris Life Sciences and Flatiron Health partnership creates a multimodal data offering to support and accelerate biopharmaceutical drug development and patient care. The company has 16 active competitors, including 3 that have exited. Feb 15, 2018 · Swiss drugmaker Roche Holding AG said on Thursday it would buy the rest of U. Roche has completed the acquisition of healthcare technology and services company Flatiron Health for $1. 9 billion, according to a media report. These subsidiaries are from the health care and pharmaceutical industries. Roche embarked on strategic partnerships with Foundation Medicine (FMI) and Flatiron Health several years ago because we recognise that combining high-quality genomics with real-world data (patient data from clinical practice) delivers completely new approaches. Flatiron Health is a market leader in oncology-specific electronic health record (EHR) software as well as in the curation and development of Feb 16, 2018 · The big headline out of the health care M&A world today is Swiss pharmaceutical giant Roche’s $1. RHI is 100% indirectly owned by Roche Holding Ltd, a public company registered in Switzerland and the parent company of the Roche Group. 9 billion acquisition of Flatiron Health, a healthcare technology and services company whose Flatiron Health is a healthcare technology company that aims to improve lives by learning from the experience of every cancer patient. Most of the Roche executives who initially backed the deal have since left, reducing Flatiron's support at the Swiss company. Aug 7, 2024 · Roche considers divesting Flatiron Health, acquired for $1. 9 billion in 2018, highlighting the challenges big pharma faces with start-up investments. Oct 9, 2024 · Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data (RWD), today announced a Apr 5, 2018 · Roche's recently announced $1. Flatiron Health is a market leader in the curation and development of real-world evidence for cancer research as well as oncology-specific electronic health record software. 9 billion acquisition of digital healthcare tech company Flatiron Health. 9B. 9 billion under a deal designed to expand the buyer’s presence in precision medicine and oncology. Aug 7, 2024 · Roche is now working with Citigroup to assess options for Flatiron, including divesting the business or selling part of the company to a partner that could help to run the business. Flatiron. Flatiron Health is a Feb 15, 2018 · Roche and Flatiron Health, Inc. Roche today acquired Flatiron Health, a leader in oncology-focused electronic health decision-making software and Flatiron Health is a healthcare technology company that aims to improve lives by learning from the experience of every cancer patient. Feb 15, 2018 · In 2016, Roche led a $175 million investment into Flatiron, in part to help the Swiss company harness the deluge of still-underutilized data collected from cancer patients with the New York City Aug 13, 2024 · In February 2018, Roche Pharmaceuticals acquired Flatiron Health, a company specializing in oncology data, for $1. Explore our open positions and apply today! Feb 5, 2025 · Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research, and Exact Sciences, a leading provider of can Nov 12, 2024 · Tempus AI, Inc. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern Flatiron Health is an independent affiliate of the Roche Group. We’re building a diverse, global workforce of kind and passionate people to propel our mission forward. Flatiron Health expands global oncology research network, tripling partnerships in the UK, Germany, and Japan, enhancing real-world data research to improve cancer care worldwide. Flatiron Health has raised $314M in funding from Google Ventures and Roche, with last known valuation of $1. Flatiron is partnered with over 260 community cancer clinics and 14 of the top 15 cancer companies. oroxxzylmeuuuztvrwobeivixgbnnjgireqciybmvutkyujoihimsxtkdvxcrecqryivsjgbdfiyf